I. Optimal treatment for papillary thyroid carcinoma: Total thyroidectomy is the recommended treatment for all papillary thyroid carcinoma (PTC)

Acta Oto-Rhino-Laryngologica Belgica

Volumn 53, Issue 3, 1999, Pages 161-164

  Santini, Jacques ^a,b   Haddad, A ^a  

^a PASTEUR HOSPITAL   (France)

^b UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

Papillary thyroid carcinoma; Prognosis; Surgery

Indexed keywords

RADIOACTIVE IODINE;

ARTICLE; CANCER RECURRENCE; CERVICAL LYMPH NODE; HIGH RISK PATIENT; LYMPH NODE DISSECTION; MORTALITY; PATIENT SELECTION; PROGNOSIS; RISK ASSESSMENT; SUBTOTAL THYROIDECTOMY; THYROID CARCINOMA; THYROIDECTOMY;

CARCINOMA, PAPILLARY; HUMANS; PROGNOSIS; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 0032714720     PISSN: 00016497     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. HUNDAHL S.A., FLEMING I. D., FREMGEN A. M., MENCK H. R. A national cancer date base report on 53, 856 cases of thyroid carcinoma treated in the U.S. 1885-1995. Cancer, 83 : 2638-2648, 1998.
2. CADY B., ROSSI R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery, 104 : 947-953, 1988.
3. HAY I. D., BERGSTRALH E. J., GOELLNER J. R., EBERSOLD J. R., GRANT C. S. Predicting outcome in papillary thyroid carcinoma : development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery, 114 : 1050-1058, 1993.
4. MAZZAFERRI E., JHIANG S. M. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am. J. Med., 97 : 418-428, 1994.
5. NOGUCHI M., KATEV N., MIWA K. Therapeutic strategy and long term results in differentiated thyroid cancer. Surg. Oncol., 67 : 52-59, 1998.
6. VARMA V. M., BEIERWALTES W. H., NOFAI M. M. et al. Treatment of thyroid cacer. Dath rates after surgery and after surgery followed by sodium iodide 1. JAMA, 214 : 1437-1442, 1970.
7. BEIERWALTES W. The treatment of thyroid carcinoma with radioactive iodine. Semin. Nucl. Med., 8 : 79-94, 1978.
8. SWEENEY D. C., Johnston G. S. Radioiodine therapy for thyroid cancer. Endocrinol. Metab. Clin. North Am., 24 : 695-665, 1995.
9. GRIGSBY P. W., BAGLAN K., SIEGEL B. A. Surveillance of patients to detect recurrent thyroid carcinoma. Cancer, 85 : 945-51, 1999.
10. ROELANTS V., DE NAYER P., BOUCKAERT A, BECKERS C. The predictive value of serum thyroglobulin in the follow-up of differentiated thyroid cancer. Eur. J. Nucl. Med., 24 : 722-727, 1997.
11. TSANG R. W., BRIERLEY J. D., SIMPSON W. J., PANZARELLA T., GOSPODAROWICZ M. K., SUTCLIFFE S. B. The effect of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer, 82 : 375-388, 1998.
12. CHEN H., UDELSMAN R. Papillary thyroid carcinoma. Justification for total thyroidectomy and management of lymph nodes metastases. Surg. Oncol. Clin. North Am., 7 : 645-663, 1998.